ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

BACKGROUND: Dolutegravir (DTG)-based antiretroviral therapy (ART) is highly effective and well-tolerated in adults and is rapidly being adopted globally. We describe the design of the ODYSSEY trial which evaluates the efficacy and safety of DTG-based ART compared with standard-of-care in children an...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Cecilia L., Turkova, Anna, Mujuru, Hilda, Kekitiinwa, Adeodata, Lugemwa, Abbas, Kityo, Cissy M., Barlow-Mosha, Linda N., Cressey, Tim R., Violari, Avy, Variava, Ebrahim, Cotton, Mark F., Archary, Moherndran, Compagnucci, Alexandra, Puthanakit, Thanyawee, Behuhuma, Osee, Saϊdi, Yacine, Hakim, James, Amuge, Pauline, Atwine, Lorna, Musiime, Victor, Burger, David M., Shakeshaft, Clare, Giaquinto, Carlo, Rojo, Pablo, Gibb, Diana M., Ford, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809782/
https://www.ncbi.nlm.nih.gov/pubmed/33446115
http://dx.doi.org/10.1186/s12879-020-05672-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809782/
https://www.ncbi.nlm.nih.gov/pubmed/33446115
http://dx.doi.org/10.1186/s12879-020-05672-6

Ejemplares similares